1. Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma Surgery
- Author
-
Emmanuel Mandonnet, Hamid Mammar, Pierre-Olivier Champagne, Anne-Laure Bernat, Bernard George, Sébastien Froelich, Jerome Cartailler, Thibault Passeri, Jean Guichard, Paolo di Russo, Homa Adle-Biassette, and Lorenzo Giammattei
- Subjects
medicine.medical_specialty ,Subgroup analysis ,Skull Base Neoplasms ,Gastroenterology ,Preoperative care ,Internal medicine ,Chordoma ,medicine ,Humans ,Tumor growth ,Progression-free survival ,Pathological ,Retrospective Studies ,Therapeutic strategy ,medicine.diagnostic_test ,business.industry ,fungi ,Magnetic resonance imaging ,medicine.disease ,Progression-Free Survival ,Survival Rate ,Surgery ,Neurology (clinical) ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies - Abstract
BACKGROUND Currently, different postoperative predictors of chordoma recurrence have been identified. Tumor growth rate (TGR) is an image-based calculation that provides quantitative information of tumor's volume changing over time and has been shown to predict progression-free survival (PFS) in other tumor types. OBJECTIVE To explore the usefulness of TGR as a new preoperative radiological marker for chordoma recurrence. METHODS A retrospective single-institution study was carried out including patients reflecting these criteria: confirmed diagnosis of chordoma on pathological analysis, no history of previous radiation, and at least 2 preoperative thin-slice magnetic resonance images available to measure TGR. TGR was calculated for all patients, showing the percentage change in tumor size over 1 mo. RESULTS A total of 32 patients were retained for analysis. Patients with a TGR ≥ 10.12%/m had a statistically significantly lower mean PFS (P
- Published
- 2021
- Full Text
- View/download PDF